Aurora Cannabis Inc. ("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and CannaRoyalty Corp.
Canopy Growth Corporation ("Canopy Growth") (TSX:WEED) (NYSE:CGC) and Hiku Brands Company Ltd. ("Hiku") (CSE:HIKU) (together, the "Companies") are pleased to announce that they have entered into a definitive arrangement agreement (the "Agreement") pursuant to which Canopy Growth will acquire all of the issued and outstanding common shares of Hiku (the "Transaction").
CROP Infrastructure Corp. (CSE:CROP) (OTC:CRXPF) (“CROP” or the “Company”) announced today it has entered into a member interest purchase agreement with Elite Ventures LLC, of Nevada, to acquire a 49% member interest in a Nye County agricultural property. The company has agreed to pay $1,300,000 USD, in cash, for the member interest and has paid $600,000 to date.
During the last quarter, Canadian cannabis stocks have recorded mixed movements on average and the sector has rallied well off its lows. Canadian cannabis producers continue to be closely watched by investors (institutional and retail) as companies have been accepted to list on major stock exchanges, like the Nasdaq and NYSE.
MedReleaf Corp. (TSX:LEAF) ("MedReleaf" or the "Company") and BioPharma Services Inc. (BioPharma) today announced they have entered into an exclusive agreement to conduct clinical research for cannabis and cannabis derived products. Under the agreement BioPharma will become an extension of MedReleaf's clinic development team.
Emblem Corp. (TSX-V:EMC and EMC.WT) (“Emblem” or the “Company”), a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), today reported financial and operating results for the first quarter ended March 31, 2018.
Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has entered into a series of agreements (the "Transaction") resulting in Aphria forming a joint venture, CannInvest Africa Ltd. ("CannInvest"), with South African company Verve Group of Companies ("VGC").
Liberty Health Sciences Inc. (CSE: LHS (https://libertyhealthsciences.com/investor/) ) (OTCQX: LHSIF) ("Liberty" or the "Company") today announced the expansion of the Company's partnership with Colorado-based MM Technology Holdings, LLC ("Mary's") to be the exclusive provider of the award-winning line of Mary's Medicinals® cannabis products in Massachusetts.
Aurora Cannabis Inc. ("Aurora") (TSX: ACB) and MedReleaf Corp.